19-43592724-C-G
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001007561.3(IRGQ):c.1174G>C(p.Glu392Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,458,710 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E392D) has been classified as Uncertain significance.
Frequency
Consequence
NM_001007561.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IRGQ | ENST00000422989.6 | c.1174G>C | p.Glu392Gln | missense_variant | Exon 3 of 3 | 5 | NM_001007561.3 | ENSP00000387535.1 | ||
IRGQ | ENST00000602269.2 | c.1174G>C | p.Glu392Gln | missense_variant | Exon 2 of 2 | 1 | ENSP00000472250.1 | |||
ENSG00000268361 | ENST00000594374.1 | c.168+144G>C | intron_variant | Intron 1 of 2 | 3 | ENSP00000472698.1 | ||||
IRGQ | ENST00000601520.1 | n.251+33G>C | intron_variant | Intron 1 of 1 | 3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1458710Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 725830 show subpopulations
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1174G>C (p.E392Q) alteration is located in exon 3 (coding exon 2) of the IRGQ gene. This alteration results from a G to C substitution at nucleotide position 1174, causing the glutamic acid (E) at amino acid position 392 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at